Faqja 1 nga 30 rezultatet
Observation of two-photon excitation (760 nm) and emission of two responsive water soluble europium complexes is reported with cross-sections of up to 2 GM. Two-photon excitation spectra have also been measured, acquisition being achieved by the use of a cavity-dumped mode locked Ti-sapphire laser.
We report here a new detection method for DNA hybrids on dot blots. The process utilizes DNA or oligonucleotide probes labeled with biotin, followed by recognition with a conjugate of streptavidin and europium cryptate, a time-resolved fluorescent label. Unlike the other lanthanide chelates, this
A europium pyrosilicate, Eu2MgSi2O7 (1), is obtained using a high-temperature solid-state reaction. It crystallizes in the tetragonal noncentrosymmetric space group P4[combining macron]21m, and its structure features a 2D structure built by SiO4 and MgO4 tetrahedra, resulting in interlayer cavities
Phosphorylated p53 proteins are biomarkers with clinical utility for early diagnosis of cancer, but difficult to quantify. An inductively coupled plasma mass spectrometry (ICP-MS) based immunoassay is described here that uses uniform lanthanide nanoparticles (NPs) as elemental tags for the
The association of trivalent f-elements-Eu(III), Am(III), and Cm(III)--with cellulose, chitin, and chitosan was determined by batch experiments and time-resolved, laser-induced fluorescence spectroscopy (TRLFS). The properties of these biopolymers as an adsorbent were characterized based on
Achieving an efficient separation of chemically similar Am(3+)/Eu(3+) pair in high level liquid waste treatment is crucial for managing the long-term nuclear waste disposal issues. The use of sophisticated supramolecules in a rigid framework could be the next step toward solving the long-standing
The fluorescence of Eu(III) is used to study the nature of the Ca(II) binding sites in the central cavity of the two-zinc(II) insulin hexamer. The dependence of the Eu(III) fluorescence lifetime upon Eu(III) stoichiometry indicates that there are three identical Eu(III) binding sites present in the
The title compound, Eu(5)Cd(2)Sb(5)O adopts the Ba(5)Cd(2)Sb(5)F-type structure (Pearson symbol oC52), which contains nine crystallographically unique sites in the asymmetric unit, all on special positions. One Eu, two Sb, and the Cd atom have site symmetry m..; two other Eu, the third Sb and the O
The rare earth cryptates are used as long-lived fluorescent labels. They are formed by inclusion of a europium ion in the intramolecular cavity of a macropolycyclic ligand containing bipyridine groups as light absorbers. The use of fluoride ions in the measuring medium allows a total shielding of
Fluoride binding by a series of europium and ytterbium complexes of DOTA-tetraamide ligands derived from primary, secondary and tertiary amides has been studied by NMR and luminescence spectroscopies. In all the systems studied, fluoride binding results in a change in the nature of the magnetic
Lanthanide complexes (Ln=Eu, Tb, and Yb) that are based on a C2 -symmetric cyclen scaffold were prepared and characterized. The addition of fluoride anions to aqueous solutions of the complexes resulted in the formation of dinuclear supramolecular compounds in which the anion is confined into the
Luminescent europium (Eu) and dysprosium (Dy) doped yttrium-vanadate (Y-V) nanoparticles (NPs) were synthesized in the cavity of the protein, apoferritin. Y-V NPs were synthesized by incubating a solution of apoferritin with Y(3+) and VO3(-) ions in the presence of ethylene diamine-N-N'-diacetic
Nitrogen and sulfur codoped carbon-based dots (N,S-CDs) with strong blue light emission are encapsulated into red light-emitting europium metal-organic frameworks (Eu-MOFs) to form two color light-emitting nanohybrids (Eu-MOFs/N,S-CDs). In organic solvents, the encapsulated N,S-CDs are aggregated
Six new coordination polymers, [Eu(1,2-BDC)(1,2-HBDC)(phen)(H(2)O)](n) (1), [Eu(2)(1,3-BDC)(3)(phen)(2)(H(2)O)(2)](n).4nH(2)O (2), [Eu(1,4-BDC)(3/2)(phen)(H(2)O)](n) (3), [Yb(2)(1,2-BDC)(3)(phen)(H(2)O)(2)](n).3.5nH(2)O (4), [Yb(2)(1,3-BDC)(3)(phen)(1/2)](n) (5), and
Cancer antigen 125 (CA 125) is widely used as diagnostic biomarker for ovarian cancer. Change in the concentration level of CA 125 is associated with disease progression or regression. CA 125 posseses a phosphorylation site and protein backbone is phosphorylated on serine, before secretion. In this